The haemodynamic and catecholamine response to xenon/remifentanil anaesthesia in Beagle dogs

Laboratory Animals

Volumn 42, Issue 3, 2008, Pages 338-349

  Francis, Roland C E ^a   Reyle Hahn, Matthias S ^b   Höhne, Claudia ^c   Klein, Adrian ^a   Theruvath, Ilka ^d   Donaubauer, Bernd ^c   Busch, Thilo ^c   Boemke, Willehad ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Evangelisches Waldkrankenhaus Spandau ^*  (Germany)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Anaesthesia; Cardiovascular; Catecholamine; Haemodynamic; Xenon

Indexed keywords

ADRENALIN; ALDOSTERONE; ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; CATECHOLAMINE; ENDOTHELIN 1; INHALATION ANESTHETIC AGENT; ISOFLURANE; NITROUS OXIDE; NORADRENALIN; PROPOFOL; REMIFENTANIL; RENIN; VASOPRESSIN; XENON;

ALDOSTERONE BLOOD LEVEL; ANESTHESIA; ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; BRADYCARDIA; CARDIOVASCULAR FUNCTION; CENTRAL VENOUS PRESSURE; COMBINATION CHEMOTHERAPY; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONSCIOUS SEDATION; CONTROLLED STUDY; DOG; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG SAFETY; FEMALE; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HEMODYNAMICS; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MEAN ARTERIAL PRESSURE; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; NONHUMAN; PLASMA RENIN ACTIVITY; PROTEIN BLOOD LEVEL; PULMONARY ARTERY OCCLUSION PRESSURE; SYSTEMIC VASCULAR RESISTANCE;

ALDOSTERONE; ANESTHETICS, INHALATION; ANIMALS; ATRIAL NATRIURETIC FACTOR; CARDIOVASCULAR SYSTEM; CATECHOLAMINES; DOGS; ENDOTHELIN-1; FEMALE; HEMODYNAMICS; ISOFLURANE; MODELS, ANIMAL; NITROUS OXIDE; PIPERIDINES; RANDOM ALLOCATION; RENIN; XENON;

CANIS FAMILIARIS;

EID: 47749152573     PISSN: 00236772     EISSN: None     Source Type: Journal    
DOI: 10.1258/la.2007.007048     Document Type: Article

References (41)

1. Boomsma F, Rupreht J, Man in 't Veld AJ, de Jong FH, Dzoljic M, Lachmann B (1990) Haemodynamic and neurohumoral effects of xenon anaesthesia. A comparison with nitrous oxide. Anaesthesia 45, 273-8
2. Burchardi H, Kaczmarczyk G (1994) The effect of anaesthesia on renal function. European Journal of Anaesthesiology 11, 163-8
3. Carrasco-Jimenez MS, Martin Cancho MF, Lima JR, Crisostomo V, Uson-Gargallo J, Ezquerra LJ (2004) Relationships between a proprietary index, bispectral index, and hemodynamic variables as a means for evaluating depth of anesthesia in dogs anesthetized with sevoflurane. American Journal of Veterinary Research 65, 1128-35
4. Coburn M, Kunitz O, Baumert JH, et al. (2005) Randomized controlled trial of the haemodynamic and recovery effects of xenon or propofol anaesthesia. British Journal of Anaesthesia 94, 198-202
5. Cullen D (1986) Anesthetic depth and MAC. In: Anesthesia (Miller R, ed). New York: Churchill Livingstone, 553-80
6. Davis JO, Freeman RH (1976) Mechanisms regulating renin release. Physiological Reviews 56, 1-56
7. de Sousa SL, Dickinson R, Lieb WR, Franks NP (2000) Contrasting synaptic actions of the inhalational general anesthetics isoflurane and xenon. Anesthesiology 92, 1055-66
8. Eger EI II, Brandstater B, Saidman LJ, Regan MJ, Severinghaus JW, Munson ES (1965a) Equipotent alveolar concentrations of methoxyflurane, halothane, diethyl ether, fluroxene, cyclopropane, xenon and nitrous oxide in the dog. Anesthesiology 26, 771-7
9. Eger EI II, Saidman LJ, Brandstater B (1965b) Minimum alveolar anesthetic concentration: a standard of anesthetic potency. Anesthesiology 26, 756-63
10. Francis RC, Höhne C, Kaczmarczyk G, Boemke W (2004) Effect of angiotensin II and endothelin-1 receptor blockade on the haemodynamic and hormonal changes after acute blood loss and after retransfusion in conscious dogs. Acta Physiologica Scandinavica 180, 319-28
11. Greene SA, Tranquilli WJ, Benson GJ, Grimm KA (2003) Effect of medetomidine administration on bispectral index measurements in dogs during anesthesia with isoflurane. American Journal of Veterinary Research 64, 316-20
12. Gruss M, Bushell TJ, Bright DP, Lieb WR, Mathie A, Franks NP (2004) Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Molecular Pharmacology 65, 443-52
13. Hettrick DA, Pagel PS, Warltier DC (1996) Desflurane, sevoflurane, and isoflurane impair canine left ventricular-arterial coupling and mechanical efficiency. Anesthesiology 85, 403-13
14. Hettrick DA, Pagel PS, Kersten JR, et al. (1998) Cardiovascular effects of xenon in isoflurane-anesthetized dogs with dilated cardiomyopathy. Anesthesiology 89, 1166-73
15. Höhne C, Francis RCE, Kaczmarczyk G, Boemke W (2002) Haemodynamic and hormonal changes during haemorrhage in conscious dogs treated with an endothelin-A receptor antagonist. Clinical Science 103(suppl. 48), 336-339S
16. Hü neke R, Jungling E, Skasa M, Rossaint R, Luckhoff A (2001) Effects of the anesthetic gases xenon, halothane, and isoflurane on calcium and potassium currents in human atrial cardiomyocytes. Anesthesiology 95, 999-1006
17. Hü neke R, Fassl J, Rossaint R, Luckhoff A (2004) Effects of volatile anesthetics on cardiac ion channels. Acta Anaesthesiologica Scandinavica 48, 547-61
18. Institute of Laboratory Animal Research, Commission on Life Sciences, National Research Council (1996) Guide for the Care and Use of Laboratory Animals. 7th edn. Washington, DC: The National Academies Press
19. Ishiguro Y (2001) Cardiovascular effects of xenon. International Anesthesiology Clinics 39, 77-84
20. Ishiguro Y, Goto T, Nakata Y, Terui K, Niimi Y, Morita S (2000) Effect of xenon on autonomic cardiovascular control - comparison with isoflurane and nitrous oxide. Journal of Clinical Anesthesia 12, 196-201
21. Jansen JRC, Schreuder JJ, Settels JJ, Kloek JJ, Versprille A (1990) An adequate strategy for the thermodilution technique in patients during mechanical ventilation. Intensive Care Medicine 16, 422-5
22. Kienbaum P, Heuter T, Michel MC, Peters J (2000) Racemic ketamine decreases muscle sympathetic activity but maintains the neural response to hypotensive challenges in humans. Anesthesiology 92, 94-101
23. Lane GA, Nahrwold ML, Tait AR, Taylor-Busch M, Cohen PJ, Beaudoin AR (1980) Anesthetics as teratogens: nitrous oxide is fetotoxic, xenon is not. Science 210, 899-901
24. Lang E, Kapila A, Shlugman D, Hoke JF, Sebel PS, Glass PS (1996) Reduction of isoflurane minimal alveolar concentration by remifentanil. Anesthesiology 85, 721-8
25. Luttropp HH, Romner B, Perhag L, Eskilsson J, Fredriksen S, Werner O (1993) Left ventricular performance and cerebral haemodynamics during xenon anaesthesia. A transoesophageal echocardiography and transcranial Doppler sonography study. Anaesthesia 48, 1045-9
26. Lynch C III, Baum J, Tenbrinck R (2000) Xenon anesthesia. Anesthesiology 92, 865-8
27. Marx T, Froeba G, Wagner D, Baeder S, Goertz A, Georgieff M (1997) Effects on haemodynamics and catecholamine release of xenon anaesthesia compared with total i.v. anaesthesia in the pig. British Journal of Anaesthesia 78, 326-7
28. Michelsen LG, Salmenpera M, Hug CC Jr, Szlam F, VanderMeer D (1996) Anesthetic potency of remifentanil in dogs. Anesthesiology 84, 865-72
29. Myre K, Raeder J, Rostrup M, Buanes T, Stokland O (2003) Catecholamine release during laparoscopic fundoplication with high and low doses of remifentanil. Acta Anaesthesiologica Scandinavica 47, 267-73
30. Nakayama M, Kanaya N, Edanaga M, Namiki A (2003) Hemodynamic and bispectral index responses to tracheal intubation during isoflurane or sevoflurane anesthesia. Journal of Anesthesia 17, 223-6
31. Picker O, Scheeren TW, Arndt JO (2001) Inhalation anaesthetics increase heart rate by decreasing cardiac vagal activity in dogs. British Journal of Anaesthesia 87, 748-54
32. Picker O, Schindler AW, Schwarte LA, et al. (2002) Xenon increases total body oxygen consumption during isoflurane anaesthesia in dogs. British Journal of Anaesthesia 88, 546-54
33. Preckel B, Mullenheim J, Hoff J, et al. (2004) Haemodynamic changes during halothane, sevoflurane and desflurane anaesthesia in dogs before and after the induction of severe heart failure. European Journal of Anaesthesiology 21, 797-806
34. Preckel B, Weber NC, Sanders RD, Maze M, Schlack W (2006) Molecular mechanisms transducing the anesthetic, analgesic, and organ-protective actions of xenon. Anesthesiology 105, 187-97
35. Rossaint R, Reyle-Hahn M, Schulte Am Esch J, et al. (2003) Multicenter randomized comparison of the efficacy and safety of xenon and isoflurane in patients undergoing elective surgery. Anesthesiology 98, 6-13
36. Schaffer JP (1986) Modified sequentially rejective multiple test procedures. Journal of the American Statistical Association 81, 826-31
37. Schroth SC, Schotten U, Alkanoglu O, Reyle-Hahn MS, Hanrath P, Rossaint R (2002) Xenon does not impair the responsiveness of cardiac muscle bundles to positive inotropic and chronotropic stimulation. Anesthesiology 96, 422-7
38. Vagts DA, Hecker K, Iber T, et al. (2004) Effects of xenon anaesthesia on intestinal oxygenation in acutely instrumented pigs. British Journal of Anaesthesia 93, 833-41
39. Wang BC, Flora-Ginter G, Leadley RJ Jr, Goetz KL (1988) Ventricular receptors stimulate vasopressin release during hemorrhage. American Journal of Physiology 254, R204-11
40. Yamakura T, Harris RA (2000) Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels. Comparison with isoflurane and ethanol. Anesthesiology 93, 1095-101
41. Yoshida H, Kushikata T, Kubota T, Hirota K, Ishihara H, Matsuki A (2001) Xenon inhalation increases norepinephrine release from the anterior and posterior hypothalamus in rats. Canadian Journal of Anaesthesia 48, 651-5